New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
07:23 EDTDNDN, SNSSSunesis appoints Joseph DePinto as Chief Commercial Officer
Sunesis Pharmaceuticals (SNSS) announced the appointment of Joseph DePinto to the newly created position of executive vice president and Chief Commercial Officer. Prior to joining Sunesis, DePinto was Executive Vice President, Global Commercial Operations at Dendreon (DNDN).
News For SNSS;DNDN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 24, 2014
12:23 EDTSNSSSunesis December calls active
Subscribe for More Information
07:07 EDTSNSSSunesis publishes REVEAL-1 trial results
Subscribe for More Information
November 19, 2014
07:05 EDTSNSSSunesis publishes vosaroxin Phase 1b/2 AML trial results
Subscribe for More Information
November 18, 2014
07:37 EDTSNSSStifel to hold a conference
Subscribe for More Information
November 17, 2014
11:56 EDTSNSSSunesis jumps after announcing plans to present data from VALOR trial
Subscribe for More Information
November 14, 2014
16:24 EDTSNSSBiotechnology Value Fund reports 5.1% passive stake in Sunesis

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use